Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Safety and Efficacy of Cariprazine for Mania [Phase 3]

View source ↗

Summary

Phase 3 trial results assessing the safety and efficacy of cariprazine for mania in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VRAYLAR (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Disorder, Mania | Phase 3 | Status: COMPLETED | Results posted: 2017-04-17